Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

by Frédéric Debellut, MSc, Andrew Clark, PhD, Clint Pecenka, PhD, Jacqueline Tate, PhD, Ranju Baral, PhD, Colin Sanderson, ProfPhD, Umesh Parashar, MD, Deborah Atherly, PhD
Published 2021-07-01

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study

by Frédéric Debellut, MSc, Andrew Clark, PhD, Clint Pecenka, PhD, Jacqueline Tate, PhD, Ranju Baral, PhD, Colin Sanderson, ProfPhD, Umesh Parashar, MD, Laura Kallen, MPH, Deborah Atherly, PhD
Published 2019-12-01

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative sched...

by Andrew Clark, PhD, Jacqueline Tate, PhD, Umesh Parashar, MD, Mark Jit, PhD, Mateusz Hasso-Agopsowicz, PhD, Nicholas Henschke, PhD, Benjamin Lopman, PhD, Kevin Van Zandvoort, MSc, Clint Pecenka, PhD, Paul Fine, PhD, Colin Sanderson, PhD
Published 2019-11-01

Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis

by Dr. Stéphane Verguet, PhD, Zachary D Olson, MA, Joseph B Babigumira, PhD, Dawit Desalegn, MD, Kjell Arne Johansson, PhD, Margaret E Kruk, MD, Carol E Levin, PhD, Rachel A Nugent, PhD, Clint Pecenka, PhD, Mark G Shrime, MD, Solomon Tessema Memirie, MD, David A Watkins, MD, Prof. Dean T Jamison, PhD
Published 2015-05-01